Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC902127286;27287;27288 chr2:178712964;178712963;178712962chr2:179577691;179577690;179577689
N2AB870426335;26336;26337 chr2:178712964;178712963;178712962chr2:179577691;179577690;179577689
N2A777723554;23555;23556 chr2:178712964;178712963;178712962chr2:179577691;179577690;179577689
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: F
  • RefSeq wild type transcript codon: TTT
  • RefSeq wild type template codon: AAA
  • Domain: Ig-76
  • Domain position: 3
  • Structural Position: 3
  • Q(SASA): 0.1887
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
F/L rs754185678 -1.713 0.948 N 0.649 0.701 0.448696893172 gnomAD-2.1.1 4.05E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.95E-06 0
F/L rs754185678 -1.713 0.948 N 0.649 0.701 0.448696893172 gnomAD-4.0.0 1.59495E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86541E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
F/A 0.9695 likely_pathogenic 0.9834 pathogenic -2.725 Highly Destabilizing 0.996 D 0.805 deleterious None None None None N
F/C 0.9264 likely_pathogenic 0.9577 pathogenic -1.462 Destabilizing 1.0 D 0.851 deleterious D 0.569214117 None None N
F/D 0.9952 likely_pathogenic 0.9978 pathogenic -1.924 Destabilizing 1.0 D 0.863 deleterious None None None None N
F/E 0.9953 likely_pathogenic 0.9977 pathogenic -1.823 Destabilizing 1.0 D 0.864 deleterious None None None None N
F/G 0.9929 likely_pathogenic 0.9966 pathogenic -3.078 Highly Destabilizing 1.0 D 0.852 deleterious None None None None N
F/H 0.9768 likely_pathogenic 0.9866 pathogenic -1.283 Destabilizing 1.0 D 0.773 deleterious None None None None N
F/I 0.5088 ambiguous 0.5945 pathogenic -1.629 Destabilizing 0.733 D 0.472 neutral N 0.489330542 None None N
F/K 0.9971 likely_pathogenic 0.9985 pathogenic -1.493 Destabilizing 1.0 D 0.863 deleterious None None None None N
F/L 0.9574 likely_pathogenic 0.9746 pathogenic -1.629 Destabilizing 0.948 D 0.649 neutral N 0.513074018 None None N
F/M 0.8439 likely_pathogenic 0.8935 pathogenic -1.276 Destabilizing 0.999 D 0.738 prob.delet. None None None None N
F/N 0.9869 likely_pathogenic 0.9936 pathogenic -1.543 Destabilizing 1.0 D 0.867 deleterious None None None None N
F/P 0.9963 likely_pathogenic 0.9981 pathogenic -1.994 Destabilizing 1.0 D 0.874 deleterious None None None None N
F/Q 0.994 likely_pathogenic 0.9968 pathogenic -1.697 Destabilizing 1.0 D 0.872 deleterious None None None None N
F/R 0.9913 likely_pathogenic 0.9951 pathogenic -0.738 Destabilizing 1.0 D 0.878 deleterious None None None None N
F/S 0.9659 likely_pathogenic 0.9835 pathogenic -2.339 Highly Destabilizing 0.999 D 0.851 deleterious D 0.545994527 None None N
F/T 0.9684 likely_pathogenic 0.9841 pathogenic -2.147 Highly Destabilizing 0.999 D 0.834 deleterious None None None None N
F/V 0.5901 likely_pathogenic 0.6773 pathogenic -1.994 Destabilizing 0.978 D 0.707 prob.neutral N 0.519061499 None None N
F/W 0.8511 likely_pathogenic 0.8893 pathogenic -0.607 Destabilizing 1.0 D 0.731 prob.delet. None None None None N
F/Y 0.6291 likely_pathogenic 0.6741 pathogenic -0.865 Destabilizing 0.998 D 0.661 neutral D 0.534727127 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.